GENE THOMAS CALLAIS

Allopathic & Osteopathic Physicians|Family Medicine BROUSSARD, LA NPI 1528315280

General Payments — all program years on this page

$3,922.57

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 244
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $718.46 across 40 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $718.4640

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $468.3228
2019 $491.7031
2020 $143.269
2021 $621.4739
2022 $702.6846
2023 $776.6851
2024 $718.4640

Records — PY2024 (40)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086138515 Bayer Healthcare Pharmaceuticals Inc. $15.76 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086763459 Novartis Pharmaceuticals Corporation $14.63 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086763465 Novartis Pharmaceuticals Corporation $19.31 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086763469 Novartis Pharmaceuticals Corporation $17.49 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086763471 Novartis Pharmaceuticals Corporation $17.52 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086763473 Novartis Pharmaceuticals Corporation $24.62 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096654631 Novo Nordisk Inc $18.51 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096670090 Novo Nordisk Inc $18.35 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096719474 Novo Nordisk Inc $12.94 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096764301 Novo Nordisk Inc $17.02 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096877778 Novo Nordisk Inc $24.02 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096914882 Novo Nordisk Inc $14.95 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097216917 Novo Nordisk Inc $20.11 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097399157 Novo Nordisk Inc $13.27 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103406089 ABBVIE INC. $30.97 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103406091 ABBVIE INC. $21.20 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104478974 AstraZeneca Pharmaceuticals LP $13.09 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114605466 Exact Sciences Corporation $17.50 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114605470 Exact Sciences Corporation $17.89 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114605474 Exact Sciences Corporation $17.50 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115946417 GlaxoSmithKline, LLC. $13.72 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796497 Insulet Corporation $18.83 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796499 Insulet Corporation $16.90 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117216056 Amgen Inc. $14.91 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117216058 Amgen Inc. $15.21 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117216060 Amgen Inc. $17.77 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117216062 Amgen Inc. $14.33 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125110953 Abbott Laboratories $16.40 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125110955 Abbott Laboratories $23.03 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134985798 Lilly USA, LLC $14.44 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134985800 Lilly USA, LLC $17.18 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134996444 Lilly USA, LLC $17.42 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134997792 Lilly USA, LLC $19.77 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138714418 Tolmar, Inc. $15.96 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138718696 Tolmar, Inc. $16.43 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138797610 Edwards Lifesciences Corporation $32.25 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143202048 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.02 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151045276 Phathom Pharmaceuticals, Inc. $15.35 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153301215 Dexcom, Inc. $21.91 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153542300 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.98 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.